Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cancer vaccine
Biotech
Sellas jettisons 2 execs while awaiting ph. 3 cancer vax readout
Chief Commercial Officer Robert Francomano will be departing along with General Counsel and Corporate Secretary Barbara Wood.
Gabrielle Masson
Mar 8, 2024 10:09am
Ultimovacs' cancer vaccine flunks another checkpoint combo test
Mar 7, 2024 6:14am
Gritstone lays off 40% of team after delaying COVID vax trial
Feb 29, 2024 4:05pm
Bavarian Nordic halts cancer vaccine program
Feb 21, 2024 7:25am
Elicio vaccine boosts T-cell therapy response to tumors in mice
Jan 29, 2024 10:53am
ISA's cancer vaccine fails in ph. 2, Regeneron loses interest
Dec 12, 2023 8:53am